Only 100 million shares in issue, 6.25p to buy at present. I own these shares and expect this share to reach between 12-16p by september. it is very good value at present to buy.

The company expects to announce its interim results for the six months ended 30
June 2006 in September.

Based on unaudited information the directors expect core revenues, being the
supply of tissue samples and derivatives and the provision of drug discovery
services, to be not less than 3.7 million. In addition, revenues of 350,000
have been received relating to the licensing of the R4 programme.


At 30 June 2006 the company had cash resources of 6.2 million.


Furthermore, Asterand PLC said it is to offer drug discovery services to the Japanese market through a deal with Mitsui Corporation and Toyobo Co Ltd.

The human tissue research company said it will supply Japanese drug discovery companies with biological samples, data and research services covering a range of diseases, including cancer, gastrointestinal, respiratory, metabolic disorders, inflammatory, cardiovascular, as well as diseases of the Central Nervous System such as Alzheimer's.

this is a good one to Buy and stock as many as you can at these levels. However as usual DO YOUR OWN RESEARCH.

The directors of Lo-Q (AIM: LOQ), e-Therapeutics plc (AIM: ETX), Asterand (LSE: ATD) and Norcon Plc (AIM: NCON) will be presenting:
Thursday the 3rd March 2011, Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB

The presentations will start at 6:00pm and finish at approx 8.00pm. After the presentations are complete the directors will also be available to take questions during a free canapand wine reception. Details on the presenting companies can be found below.

This event is suitable for the following:
Sophisticated & private investors, private client brokers, fund managers, financial institutions, hedge funds, buy & sell side analysts and journalists.

FREE registration - http://www.proactiveinvestors.co.uk/register/event_details/102

If you have any problems registering or queries please email events@proactiveinvestors.com.au.